Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8595245 | Journal of Stroke and Cerebrovascular Diseases | 2018 | 7 Pages |
Abstract
Hyperosmolar therapy was not associated with better 3-month mRS outcomes for ICH cases in the ERICH study. This finding likely resulted from greater hyperosmolar therapy use in patients with edema and herniation rather than those agents leading to worse outcomes. Further studies should be performed to determine if hyperosmolar agents are effective in preventing poor outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Manan MD, Lee MD, MS, Jennifer MD, Padmini MS, Charles J. PhD, Jennifer RN, BSN, Anastasia BA, Daniel MD, MS,